Clinical Trial Update: To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis

View source ↗

Summary

This completed clinical trial, sponsored by Merck KGaA, evaluated factors that predict depression in patients with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: COMPLETED